Cipla concludes divestment of Cipla Vet, Cipla Agrimed

02 Jun 2017 Evaluate

Cipla has fulfilled the closing condition in relation to the divestment of Cipla Agrimed Proprietary (Cipla Agrimed), South Africa and Cipla Vet Proprietary (Cipla Vet), South Africa. Consequently, Cipla Vet and Cipla Agrimed have ceased to be subsidiaries of Inyanga Trading 386 Proprietary with effect from June 01, 2017.

Earlier in March, the company had entered into agreements, through its wholly owned subsidiary Inyanga Trading 386 Proprietary (Inyanga), with the group companies of Ascendis Health, South Africa for divesting its animal health business in South Africa and Sub-Saharan Africa.

Cipla Agrimed operates in the farm animals segment, with sales mainly attributable to agricultural co-operatives and bulk farm purchasing organizations. Cipla Agrimed has a leading position in antimicrobials and endectocides in South Africa.

Cipla Vet operates in the companion animal segment with sales primarily to wholesalers. Cipla Vet has a strong presence in the South African market, with leading positions in Proton Pump Inhibitors, Non-steroidal Anti-inflammatory Drugs (NSAIDs) and supplements.


Cipla Share Price

1414.75 9.35 (0.67%)
26-Apr-2024 09:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1529.90
Dr. Reddys Lab 6239.60
Cipla 1414.75
Zydus Lifesciences 951.00
Lupin 1585.60
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.